Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRX | AZN | AMGN | GILD | BMY |
| Company | Tscan Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.0400 | 204.75 | 345.45 | 139.24 | 59.12 |
| High | 1.0800 | 204.75 | 348.17 | 140.71 | 59.63 |
| Low | 1.0250 | 202.73 | 340.64 | 138.85 | 58.77 |
| Latest | 1.0400 | 202.83 | 342.57 | 140.13 | 59.33 |
| Change | +0.0300 | -0.66 | -5.37 | +0.42 | -0.27 |
| % Change | +2.97% | -0.32% | -1.54% | +0.30% | -0.45% |
| Volume | 806,200 | 1,554,600 | 2,144,000 | 3,922,100 | 7,954,300 |
| 20-Day Average Volume | 597,770 | 1,843,460 | 2,656,585 | 6,098,890 | 13,595,970 |
| Previous Close | 1.0100 | 203.49 | 347.94 | 139.71 | 59.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0604 | 191.84 | 356.97 | 141.07 | 59.27 |
| 20-Day Raw Stochastic | 35.29% | 91.41% | 4.89% | 40.28% | 49.87% |
| 20-Day Relative Strength | 48.96 | 59.31 | 40.30 | 48.50 | 50.88 |
| Weighted Alpha | +4.40 | +51.83 | +19.34 | +34.69 | +23.73 |
| Today's Opinion | 72% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 64% Sell | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.21% since 03/27/26 | +7.65% since 03/27/26 | -1.78% since 03/27/26 | +4.38% since 03/27/26 | +1.35% since 03/27/26 |
| Low | 0.9200 on 03/30/26 | 192.61 on 03/30/26 | 340.64 on 04/06/26 | 133.89 on 03/30/26 | 58.77 on 04/06/26 |
| High | 1.0800 on 04/06/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -7.14% since 03/06/26 | +4.43% since 03/06/26 | -7.30% since 03/06/26 | -2.64% since 03/06/26 | -1.59% since 03/06/26 |
| Low | 0.9200 on 03/30/26 | 182.39 on 03/24/26 | 340.64 on 04/06/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 1.2600 on 03/10/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -8.77% since 01/06/26 | +6.80% since 01/06/26 | +3.76% since 01/06/26 | +15.47% since 01/06/26 | +9.02% since 01/06/26 |
| Low | 0.8950 on 02/06/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 1.2654 on 01/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -49.27% since 10/06/25 | +18.63% since 10/06/25 | +16.47% since 10/06/25 | +23.38% since 10/06/25 | +31.44% since 10/06/25 |
| Low | 0.8824 on 12/19/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 112.82 on 10/07/25 | 42.52 on 10/29/25 |
| High | 2.5700 on 10/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 57,471 | 315,594,272 | 187,563,328 | 173,411,136 | 121,687,400 |
| Shares Outstanding, K | 56,902 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 10,330,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -129,770,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 2,570,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -22,980,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.02 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 03/04/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.17 | 17.21 | 10.04 |